Mice receiving receptor-deficient OT-I CD8 T cells also had more tumor infiltrating CD8+ cells and expressed fewer markers associated with exhaustion compared to wildtype recipients (Fig. 2F–H, Supplementary Fig. 3). Here, CD8A is linked to neoplasm.